UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934

For the month of April, 2019

Commission File Number 000-29338

CORREVIO PHARMA CORP.
(Translation of registrant’s name into English)

1441 Creekside Drive, 6th Floor
Vancouver, BC V6J 4S7
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [   ] Form 40-F [ X ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [   ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [   ]

Exhibit	Description
99.1	Notice of meeting and record date for AGSM on June 18, 2019

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		CORREVIO PHARMA CORP.
		(Registrant)
Date: April 12, 2019	By:	/s/ Justin Renz
	Name:	Justin Renz
	Title:	President and Chief Financial Officer